[Urination disorders and parkinson disease].
Blanchard-Dauphin
A
A
Service de médecine physique et réadaptation, Hôpital Swynghedauw, CHRU, Lille. a-blanchard-dauphin@chru-lille.fr
D000368:Aged; D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003937:Diagnosis, Differential; D004298:Dopamine / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D019578:Multiple System Atrophy / Q000175:diagnosis / Q000503:physiopathology; D009434:Neural Pathways / Q000187:drug effects / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001743:Urinary Bladder / Q000294:innervation; D014555:Urination Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D014563:Urodynamics / Q000187:drug effects / Q000502:physiology
D000978:Antiparkinson Agents; D004298:Dopamine